Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) COVID-19 vaccines (28)
- (-) Scheduling (national classification system) (7)
- Medicine safety (43)
- Prescription medicines (40)
- COVID-19 (30)
- Advertising (26)
- Regulatory compliance (26)
- Therapeutic goods regulation (23)
- Safety (17)
- Listed medicines (13)
- Non-prescription medicines (13)
- Complementary medicines (12)
- Legislation (11)
- Manufacturing (10)
- Over the counter (OTC) medicines (9)
- Australian Register of Therapeutic Goods (ARTG) (7)
- Vaping hub (7)
- Compliance and enforcement hub (6)
- Import and export (6)
- Labelling and packaging (5)
- Medical devices safety (5)
- Medicinal cannabis hub (5)
- Shortages (5)
- Alert/Advisory (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Assessed listed medicines (2)
- Cosmetics (2)
- Weight loss products (2)
- Advisory bodies and committees (1)
- Sunscreens (1)
Search
35 result(s) found, displaying 1 to 25
-
COVID-19 vaccine safety reportsIn line with the official end of the COVID-19 emergency response, this will be our last regular COVID-19 Vaccine Safety Report. We will continue safety monitoring of COVID-19 vaccines.
-
NoticesWe've granted a labelling exemption for the COVID-19 Vaccine, Pfizer (raxtozinameran), under the current Poisons Standard.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NewsFind out about changes to choline salicylate access, starting from October 2023.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NewsStay updated about the commencement of MDMA and psilocybin for the treatment of certain mental illnesses.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has published a final decision to reduce the maximum size of packs for various paracetamol products.
-
Media releasesFrom 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
-
Media releasesThe TGA has approved Moderna Australia’s application to transition its COVID-19 vaccine, SPIKEVAX (elasomeran), from provisional to full registration.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
BlogFrom 1 July 2023, authorised psychiatrists can prescribe psychedelic medicines to people with specific mental health conditions under strict controls.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.